🚴♀️💰 Cycling in France: 2,000 deaths avoided each year and 5 billion euros saved for public health. Every kilometre cycled = €1 of social health costs prevented. Doubling possible with just 25% of short car journeys transferred to cycling..
Summary
🔴🔑AT THE HEART OF THE SUBJECT: Analytical summary, Key points to remember, Action points for stakeholders, Additional references
➕🛠️ ADDITIONAL RESOURCES: Cross-sectional analysis, Multiple choice questions, Frequently asked questions, Easy to Read and Understand
Source: 📒 The untapped health and climate potential of cycling in France: a national assessment from individual travel data -📜🔗LINK
Context and challenges
Using the 2019 French national travel survey, this study quantifies the health, economic and climate impacts of cycling in a low‑cycling country such as France. Adults aged 20–89 cycled on average 1 min 17 s per day, corresponding to 4.64 billion kilometers annually, with men accounting for 72.2% of total cycled distance and marked age and sex disparities. Current cycling levels already prevent an estimated 1,919 premature deaths and 5,963 chronic disease cases (type 2 diabetes, cardiovascular disease, breast and colon cancers, dementia) in 2019. A burden‑of‑disease approach (DALYs) shows that about 81% of the health gains come from reduced mortality rather than morbidity.
Operational contributions
The study shows that cycling generates €191 million in direct medical cost savings and €4.75–4.8 billion in avoided intangible costs per year, corresponding to about €1.02 in health‑related social costs prevented for every kilometer cycled and a 25:1 ratio between intangible and tangible costs. A realistic modal shift scenario in which 25% of short car trips (<5 km) are shifted to cycling nearly doubles the number of deaths prevented (≈1,800 additional deaths avoided) and yields €2.59 billion in extra intangible cost savings, while reducing CO2 emissions by 0.257 Mt annually. The authors benchmark these effects against other public policies (road safety, reduced alcohol consumption, home energy retrofits), showing that cycling performs on par with major public health interventions in terms of deaths averted. These findings provide robust quantitative evidence to guide local and national policies on active mobility, chronic disease prevention and climate mitigation.
Key points of the paper
In 2019, cycling in France prevented an estimated 1,919 premature deaths and 5,963 chronic disease cases, including 3,743 type 2 diabetes and 1,578 cardiovascular disease cases, with roughly 75% of health gains accruing to men. Health benefits correspond to 35,135 DALYs averted, 80.9% of which are due to reduced mortality, and to €191 million in direct medical savings plus €4.75–4.8 billion in avoided intangible costs, i.e. €1.02 per kilometer cycled. The analysis highlights very low average cycling exposure (1 min 17 s/day; 3.12% of adults reporting a bike trip on a given day), which explains why current benefits remain far below those seen in high‑cycling countries such as the Netherlands. A modal shift scenario moving 25% of short car trips to cycling would increase cycling exposure by about 45%, roughly double the number of deaths prevented and cut CO2 emissions by 0.257 Mt per year. Using nationally representative mobility data, health insurance incidence records and meta‑analytic dose–response functions, the study provides a robust health impact assessment framework that can be transferred to other national contexts.
Actionable directions for local stakeholders
Leverage the finding that each kilometer cycled prevents about €1 in health‑related social costs to strengthen advocacy for local cycling plans, integrating this metric into health planning documents and local health contracts. Design interventions that specifically target short car trips (<5 km), which account for 23.4% of daily journeys, by creating continuous, safe cycling infrastructure on these corridors, lowering speed limits and implementing school streets and low‑traffic neighborhoods. Address the marked gender imbalance in cycling benefits by expanding cycle training, safety‑oriented accompaniment and affordable cycling schemes tailored to women, low‑income groups and residents of disadvantaged neighborhoods. Embed active mobility within chronic disease prevention strategies (notably for type 2 diabetes and cardiovascular disease) through “cycle on prescription” schemes, partnerships between Sports–Health Houses and municipalities, and structured pathways for exercise‑based rehabilitation including cycling